Finance

Lists
Why is KREBSBIO down 2,48%?
Dive Deeper
KREBSBIO:NSE
Krebs Biochemicals And Industries Ltd
58,70 INR
-2,48%
(-1,49) 1D
19-окт., 10:35:13 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for KREBSBIO...
Open
60,80 INR
High
60,80 INR
Low
58,63 INR
Mkt. cap
1,27 млд
Avg. vol.
45,28 миң
Volume
634,00
52-wk high
76,85 INR
52-wk low
38,33 INR
EPS
-6,53 INR
Shares outstanding
13,74 млн
No. of employees
142
Open
60,80 INR
High
60,80 INR
Low
58,63 INR
Mkt. cap
1,27 млд
Avg. vol.
45,28 миң
Volume
634,00
52-wk high
76,85 INR
52-wk low
38,33 INR
EPS
-6,53 INR
Shares outstanding
13,74 млн
No. of employees
142
News stories
From web sources and news partners
About Krebs Biochemicals And Industries Ltd
CEO-
Employees142
Founded1991
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
41,67 млн
72,74 млн
68,09 млн
69,84 млн
Cost of goods sold
16,00 миң
17,00 миң
10,28 млн
4,11 млн
Cost of revenue
16,00 миң
17,00 миң
10,28 млн
4,11 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26,90 млн
26,92 млн
26,26 млн
27,79 млн
Operating expense
85,76 млн
86,06 млн
63,31 млн
71,77 млн
Total operating expenses
85,77 млн
86,08 млн
73,59 млн
75,88 млн
Operating income
-44,10 млн
-13,34 млн
-5,50 млн
-6,04 млн
Other non operating income
-
-1,00 миң
18,53 млн
-
EBT including unusual items
-61,43 млн
-31,26 млн
-23,40 млн
-24,85 млн
EBT excluding unusual items
-61,43 млн
-31,26 млн
-4,60 млн
-24,85 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
42,62 млн
42,79 млн
21,39 млн
28,10 млн
Net income
-61,43 млн
-31,26 млн
-23,40 млн
-24,85 млн
Net profit margin
-147,40%
-42,98%
-34,36%
-35,58%
Earnings per share
-
-
-
-
Interest and investment income
-
-
1,46 млн
-
Interest expense
-17,33 млн
-17,93 млн
-19,09 млн
-18,80 млн
Net interest expenses
-17,33 млн
-17,93 млн
-17,63 млн
-18,80 млн
Depreciation and amortization charges
16,24 млн
16,35 млн
15,66 млн
15,88 млн
EBITDA
-27,98 млн
2,93 млн
10,10 млн
10,02 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору